Advances in Iron Overload Therapies. Prospects for Effective Use of Deferiprone (L1), Deferoxamine, the New Experimental Chelators ICL670, GT56-252, L1NAll and their Combinations

By  

Current Medicinal Chemistry, Vol. 12, Iss. 23, 2005-11 ,pp. : 2663-2681

Bentham Science Publishers

Access to resources Recommend Favorite

Hydroxypyridone iron chelators, L1 and analogues. An 17 O NMR study

By Cerioni G.   Plumitallo A.   Batzella M.G.   Locci F.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 9, 1999-09 ,pp. : 759-763

Elsevier

Access to resources Recommend Favorite

Therapeutic value of combined therapy with Deferiprone and Silymarin as iron chelators in Egyptian Children with Beta Thalassemia major

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 15, Iss. 3, 2015-10 ,pp. : 189-195

Bentham Science Publishers

Access to resources Recommend Favorite

Bifunctional Chelators in the Design and Application of Radiopharmaceuticals for Oncological Diseases

By  

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2667-2688

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Mechanisms of Iron Uptake by Cells and the Use of Iron Chelators for the Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 12, Iss. 23, 2005-11 ,pp. : 2711-2729

Bentham Science Publishers

Access to resources Recommend Favorite